The evident beneficial effects of HM sEVs and ω3 OXLP in vitro motivated us to test their therapeutic potential in an IBD model using TNBS administered intrarectally to induce severe colonic inflammation in mice (46). Here, IGKV2D-38 is linked to inflammatory bowel disease.